$4.82 $0.22 (4.8%)

04:00 PM EST on 11/13/19

Pacific Biosciences of California, Inc. (NASDAQ:PACB)

CAPS Rating: 2 out of 5

Current Price $4.82 Mkt Cap $704.0M
Open $4.68 P/E Ratio 0.00
Prev. Close $4.60 Div. (Yield) $0.00 (0.0%)
Daily Range $4.68 - $4.84 Volume 2,940,262
52-Wk Range $4.37 - $7.50 Avg. Daily Vol. 1,832,666

Caps

How do you think NASDAQ:PACB will perform against the market?

Add Stock to CAPS Watchlist

All Players

181 Outperform
27 Underperform
 

All-Star Players

31 Outperform
12 Underperform
 

Wall Street

3 Outperform
0 Underperform
 

Top NASDAQ:PACB Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Breq (58.38)
Submitted July 19, 2016

The rational is the same as for Illumina. Genome sequencing will take on greater and greater importance in the future.

TSIF (99.97)
Submitted October 05, 2015

Releasing a lower cost option should ultimately be good for the bottom line...at least in this case.Sometimes too many models confuses customers and erodes the higher margin upper end of the offering, but in this case, the high end was so high,… More

NASDAQ:PACB VS S&P 500 (SPY)

Fools bullish on NASDAQ:PACB are also bullish on:

Fools bearish on NASDAQ:PACB are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about PACB.

Recs

0
Member Avatar FVelociraptor (99.92) Submitted: 10/24/2019 3:50:53 PM : Underperform Start Price: $4.76 NASDAQ:PACB Score: +1.61

https://velociraptor.cc

Recs

1
Member Avatar Breq (58.38) Submitted: 7/19/2016 2:25:45 PM : Outperform Start Price: $7.79 NASDAQ:PACB Score: -81.27

The rational is the same as for Illumina. Genome sequencing will take on greater and greater importance in the future.

Recs

0
Member Avatar tmjlowe (< 20) Submitted: 1/24/2015 11:17:27 PM : Outperform Start Price: $7.92 NASDAQ:PACB Score: -90.15

Their new chemistries developed for their genome long-read sequencing machines are being recognized as being the best way now to completely sequences new genomes (better than Illumina, which has trounced them up until now). This stock could really improve this year as more people recognize this is the best way to sequence new genomes.

Leaderboard

Find the members with the highest scoring picks in PACB.

Score Leader

TMFVelvetHammer

TMFVelvetHammer (62.03) Score: +503.36

The Score Leader is the player with the highest score across all their picks in PACB.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
jewbie 99.66 7/21/2011 Underperform 5Y $11.94 -59.63% +129.83% +189.46 0 Comment
cchigga 89.63 1/26/2012 Underperform 3W $4.63 +4.10% +132.16% +128.06 0 Comment
ironhide196 67.20 1/31/2012 Underperform 3Y $4.39 +9.79% +134.15% +124.35 0 Comment
MrBuku < 20 10/3/2011 Underperform 1Y $3.18 +51.57% +174.80% +123.23 0 Comment
walt373 99.91 10/3/2011 Underperform 5Y $3.18 +51.57% +174.80% +123.23 0 Comment
badgervb < 20 10/4/2011 Underperform 3M $2.97 +62.29% +185.30% +123.01 1 Comment
DarielFool 51.71 2/4/2014 Underperform 5Y $7.29 -33.88% +76.37% +110.25 0 Comment
szem 21.72 3/21/2012 Underperform 5Y $3.79 +27.18% +120.20% +93.03 0 Comment
JAW31602 41.53 3/20/2012 Underperform 3M $3.77 +27.85% +120.55% +92.70 0 Comment
Bullz3y3 < 20 11/5/2015 Underperform 5Y $7.35 -34.42% +46.82% +81.24 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for PACB.